Data on testing for COVID-19 by week and country
Data in multiple file formats with information about testing volume for COVID-19, sorted by week and country, and updated on a weekly basis.
Data on hospital and ICU admission rates and current occupancy for COVID-19
Data in multiple file formats with information about hospitalisation and Intensive Care Unit (ICU) admission rates and current occupancy for COVID-19, sorted by date and country.
Data on 14-day notification rate of new COVID-19 cases and deaths
Data in various file formats on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population and 14-day notification rate of reported deaths per million population by week and country, in the EU/EEA and the UK.
Data on the 14-day age-specific notification rate of new COVID-19 cases
The downloadable data file contains information on the 14-day notification rate of newly reported COVID-19 cases per 100 000 population by age group, week and country.
Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
This document reports on one of ECDC’s multi-country studies in the hospital setting to measure product-specific COVID-19 VE against any laboratory-confirmed SARS-CoV-2 infection among healthcare workers (HCWs) eligible for vaccination.
Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 2.0
This generic protocol for ECDC studies describes the design and methods for a prospective multi-country cohort study of hospital-based healthcare workers (HCWs) to evaluate the effectiveness of COVID-19 vaccine in preventing laboratory-confirmed SARS-CoV-2 infection.
Individuals who experience more severe COVID-19 may be at a higher risk of post COVID-19 condition symptoms
A recent ECDC report, ‘Prevalence of post COVID-19 condition symptoms: A systematic review and meta-analysis of cohort study data stratified by recruitment setting’ reveals that post –COVID-19 symptoms appear to be more prevalent amongst patients from hospital settings when compared to community settings.
Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update
This update reports on one of the ECDC multi-country studies assessing vaccine effectiveness against severe acute respiratory infection (SARI) due to laboratory-confirmed SARS-CoV-2 in the hospital setting.